title: Oesophageal cancer--an overview.
abstract: Oesophageal carcinoma is one of the most virulent malignant diseases and a major cause of cancer-related deaths worldwide. Diagnosis and accuracy of pretreatment staging have substantially improved throughout the past three decades. Therapy is challenging and the optimal approach is still debated. Oesophagectomy is considered to be the procedure of choice in patients with operable oesophageal cancer. Endoscopic measures and limited surgical procedures provide an alternative in patients with early carcinomas confined to the oesophageal mucosa. Chemotherapy and radiotherapy or concurrent chemoradiotherapy are also frequently applied, either as definitive treatment or as neoadjuvant therapy within multimodal approaches. The question of whether multimodal treatment offers improved results has been the focus of many studies since the 1990s. Although results are discordant and even some meta-analyses remain inconclusive, it is now widely accepted that multimodal therapy leads to a modest survival benefit. The role of minimally invasive oesophagectomy is not yet defined. Endoscopic stent insertion, radiotherapy and other palliative measures provide relief of tumour-related symptoms in advanced, unresectable tumour stages.
authors.affiliation: Department of General and Thoracic Surgery, Klinikum Nuremberg Nord, Prof-Ernst-Nathan-Strasse 1, D-90419 Nuremberg, Germany. michael.schweigert@klinikum-nuernberg.de
authors.forename: Michael
authors.initials: M
authors.lastname: Schweigert
authors.forename: Attila
authors.initials: A
authors.lastname: Dubecz
authors.forename: Hubert J
authors.initials: HJ
authors.lastname: Stein
mesh_terms: D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000628:therapy*; D016629:Esophagectomy / Q000379:methods; D004945:Esophagoscopy; D006801:Humans; D020360:Neoadjuvant Therapy; D010166:Palliative Care; D018714:Radiotherapy, Adjuvant; D015607:Stents